1787512759 1787504763733

Full transcript of “Face the Nation with Margaret Brennan,” Aug. 23, 2026

On this “Face the Nation with Margaret Brennan” broadcast, moderated by Margaret Brennan:  Neel Kashkari, Minneapolis Fed president and CEO Dr. Mehmet Oz, Centers for Medicare & Medicaid Services administrator   Dr. Scott Gottlieb, former FDA commissioner   Rep. Byron Donalds, Republican of Florida and candidate for governor  Rep. Seth Moulton, Democrat of Massachusetts and…

Read More
1787502322230

Transcript: Neel Kashkari, Minneapolis Fed president and CEO, on “Face the Nation with Margaret Brennan,” Aug. 23, 2026

The following is the transcript of an interview with Neel Kashkari, President and CEO of the Federal Reserve Bank of Minneapolis that aired on “Face the Nation with Margaret Brennan” on Aug. 23, 2026. MARGARET BRENNAN: For more on what’s next for the American economy, we’re joined by Neel Kashkari, President and CEO of the…

Read More
gettyimages 2289555028

Walmart says it is using $2.9 billion in tariff refunds to lower prices for shoppers

Walmart said it is using billions of dollars in tariff revenue to lower prices as the company moves to appeal to consumers experiencing an affordability pinch due to higher inflation. The Arkansas-based retailer, which reported its earnings on Thursday, has received “substantially all” of the $2.9 billion in tariff refunds it was eligible for, executive…

Read More
cbsn fusion experimental melanoma vaccine shows promising results thumbnail

Doctors explain how Moderna’s melanoma mRNA vaccine could fight deadliest form of skin cancer

Moderna is touting a “landmark moment” in its experimental melanoma treatment, saying its vaccine could help prevent the deadly skin cancer from returning or spreading. The groundbreaking clinical trial studied over 1,100 people whose melanoma was in advanced stages, taking a piece of a patient’s tumor and using it to build a shot, CBS News…

Read More
gettyimages 2287299632

Moderna stock more than doubles after melanoma vaccine trial shows “landmark moment”

Drugmaker Moderna’s stock more than doubled on Wednesday morning after the company announced a successful experimental mRNA vaccine to treat melanoma, the deadly skin cancer from which more than 8,500 people are expected to die this year. Moderna and Merck, its drug development partner, said the novel treatment prevented melanoma from returning or spreading in a…

Read More
gettyimages 2166319932

DEI policies brought no financial penalty for companies that kept them, study finds

Companies that stuck with their diversity, equity, and inclusion policies during the second Trump administration, which has sought to cut such programs from the federal government and encouraged private-sector firms to follow suit, have incurred no financial penalties, according to a new study.  Corporations in the S&P 500 that maintained their DEI programs performed just…

Read More
gettyimages 2289079330

Why SpaceX stock is falling despite strong revenue growth

Shares of SpaceX tumbled on Wednesday despite reporting strong revenue growth in its first public quarterly earnings report, as investors questioned the rocket maker’s accelerating investment in artificial intelligence. SpaceX shares tumbled $10.06, or 8%, to $115.27 in early afternoon trading on Wednesday.  Investors are worried that the company’s massive investments in artificial intelligence won’t be enough…

Read More